We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$40.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38M
3
META icon
Meta Platforms (Facebook)
META
+$23.2M
4
ORCL icon
Oracle
ORCL
+$20.4M
5
MJN
Mead Johnson Nutrition Company
MJN
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALA
301
DELISTED
Calithera Biosciences, Inc
CALA
$3.98M 0.07%
13,405
-2,855
-18% -$764K
KPTI icon
302
Karyopharm Therapeutics
KPTI
$168M
$3.96M 0.07%
29,200
+17,733
+155% +$2.62M
LH icon
303
Labcorp
LH
$24.3B
$3.95M 0.07%
29,854
+493
+2% +$60.4K
FNSR
304
DELISTED
Finisar Corp
FNSR
$3.95M 0.07%
+152,091
New +$3.79M
IDXX icon
305
Idexx Laboratories
IDXX
$42.9B
$3.91M 0.07%
+24,211
New +$3.93M
F icon
306
Ford
F
$57.3B
$3.9M 0.07%
348,886
+31,715
+10% +$354K
TSCO icon
307
Tractor Supply
TSCO
$16.3B
$3.9M 0.07%
+359,800
New +$4.28M
KHC icon
308
Kraft Heinz
KHC
$30.4B
$3.9M 0.07%
45,542
+1,325
+3% +$120K
NBL
309
DELISTED
Noble Energy, Inc.
NBL
$3.9M 0.07%
137,639
+16,999
+14% +$529K
ARRY
310
DELISTED
Array Biopharma Inc
ARRY
$3.89M 0.07%
465,000
+10,000
+2% +$81.8K
MRSH
311
Marsh
MRSH
$86.3B
$3.89M 0.07%
49,881
+933
+2% +$70.5K
EBAY icon
312
eBay
EBAY
$48.6B
$3.88M 0.07%
111,015
+599
+0.5% +$20.5K
MPC icon
313
Marathon Petroleum
MPC
$90.3B
$3.85M 0.07%
73,546
-168,856
-70% -$8.72M
GIS icon
314
General Mills
GIS
$19.2B
$3.82M 0.07%
69,006
-11,930
-15% -$681K
IBN icon
315
ICICI Bank
IBN
$106B
$3.82M 0.07%
425,700
+280,500
+193% +$2.37M
BNY
316
Bank of New York Mellon
BNY
$108B
$3.8M 0.07%
74,452
+4,859
+7% +$232K
EGRX
317
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.79M 0.07%
48,000
– –
DDC
318
DELISTED
Dominion Diamond Corporation
DDC
$3.77M 0.07%
300,000
– –
RARE icon
319
Ultragenyx Pharmaceutical
RARE
$2.65B
$3.73M 0.07%
60,000
-9,000
-13% -$542K
NOC icon
320
Northrop Grumman
NOC
$77B
$3.71M 0.07%
14,468
-170
-1% -$42.5K
EW icon
321
Edwards Lifesciences
EW
$47.6B
$3.71M 0.07%
94,194
-14,028
-13% -$512K
RVNC
322
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.7M 0.07%
140,000
+18,000
+15% +$401K
BNS icon
323
Scotiabank
BNS
$106B
$3.61M 0.07%
60,094
-4,989
-8% -$286K
HOLX
324
DELISTED
Hologic
HOLX
$3.61M 0.07%
79,542
-101,323
-56% -$4.47M
EQT icon
325
EQT Corp
EQT
$33.2B
$3.55M 0.07%
111,203
-11,808
-10% -$374K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.